VREX vs. HLVX, ANAB, SLN, YMAB, KYTX, NUVB, MNMD, IRON, PAHC, and TMCI
Should you be buying Varex Imaging stock or one of its competitors? The main competitors of Varex Imaging include HilleVax (HLVX), AnaptysBio (ANAB), Silence Therapeutics (SLN), Y-mAbs Therapeutics (YMAB), Kyverna Therapeutics (KYTX), Nuvation Bio (NUVB), Mind Medicine (MindMed) (MNMD), Disc Medicine (IRON), Phibro Animal Health (PAHC), and Treace Medical Concepts (TMCI). These companies are all part of the "medical" sector.
HilleVax (NASDAQ:HLVX) and Varex Imaging (NASDAQ:VREX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.
Varex Imaging has higher revenue and earnings than HilleVax. HilleVax is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.
HilleVax presently has a consensus price target of $30.67, suggesting a potential upside of 125.32%. Varex Imaging has a consensus price target of $27.00, suggesting a potential upside of 73.19%. Given Varex Imaging's higher possible upside, equities research analysts clearly believe HilleVax is more favorable than Varex Imaging.
86.4% of HilleVax shares are owned by institutional investors. 29.3% of HilleVax shares are owned by company insiders. Comparatively, 5.2% of Varex Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Varex Imaging had 9 more articles in the media than HilleVax. MarketBeat recorded 14 mentions for Varex Imaging and 5 mentions for HilleVax. Varex Imaging's average media sentiment score of 0.51 beat HilleVax's score of -0.27 indicating that HilleVax is being referred to more favorably in the media.
HilleVax has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Varex Imaging has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.
Varex Imaging has a net margin of 4.90% compared to Varex Imaging's net margin of 0.00%. HilleVax's return on equity of 8.34% beat Varex Imaging's return on equity.
Varex Imaging received 223 more outperform votes than HilleVax when rated by MarketBeat users. However, 100.00% of users gave HilleVax an outperform vote while only 63.64% of users gave Varex Imaging an outperform vote.
Summary
Varex Imaging beats HilleVax on 9 of the 16 factors compared between the two stocks.
Get Varex Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for VREX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VREX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Varex Imaging Competitors List
Related Companies and Tools